02425nam 2200613Ia 450 991078306720332120230617032316.00-309-16641-11-280-17629-697866101762980-309-53098-9(CKB)1000000000004081(OCoLC)70772941(CaPaEBR)ebrary10060421(SSID)ssj0000280849(PQKBManifestationID)11207293(PQKBTitleCode)TC0000280849(PQKBWorkID)10300800(PQKB)10591686(MiAaPQ)EBC3376849(Au-PeEL)EBL3376849(CaPaEBR)ebr10060421(OCoLC)923266521(EXLCZ)99100000000000408120040925d2004 my 0engurcn|||||||||txtccrIntentional human dosing studies for EPA regulatory purposes[electronic resource] scientific and ethical issues /Committee on the Use of Third Party Toxicity Research with Human Research Participants, Science, Technology, and Law Program, Policy and Global Affairs Division, National Research Council of the National AcademiesWashington, D.C. National Academies Pressc20041 online resource (226 p.)Bibliographic Level Mode of Issuance: Monograph0-309-09172-1 Includes bibliographical references.Human experimentation in medicineMoral and ethical aspectsHuman experimentation in medicineGovernment policyUnited StatesMedical ethicsMedicineResearchMoral and ethical aspectsHuman experimentation in medicineMoral and ethical aspects.Human experimentation in medicineGovernment policyMedical ethics.MedicineResearchMoral and ethical aspects.174.2/8National Research Council (U.S.).Policy and Global Affairs.National Research Council (U.S.).Committee on the Use of Third Party Toxicity Research with Human Research Participants.MiAaPQMiAaPQMiAaPQBOOK9910783067203321Intentional human dosing studies for EPA regulatory purposes3778077UNINA